Skip to main content
. 2018 Jul 18;315(5):F1295–F1306. doi: 10.1152/ajprenal.00202.2018

Fig. 4.

Fig. 4.

Effect of sodium-glucose cotransporter (SGLT)2 inhibitors (SGLT2i) on proximal tubule (PT) glucose and Na+ reabsorption at normal blood glucose concentrations. A: reduced SGLT2 glucose reabsorption through SGLT2 increases glucose delivery to and reabsorption by SGLT1 (all cases). B: SGLT2 Na+ reabsorption is reduced, but since SGLT1 reabsorbs Na+ and glucose at a 2-to-1 ratio, SGLT1 Na+ reabsorption is greatly increased, so that there is a net Na+ increase through SGLT (all cases). C and D: in cases 1 and 2, total PT Na+ reabsorption is nearly unchanged. At normal glucose levels, SGLT accounts for only a small fraction of PT Na+ reabsorption, so the effect of SGLT2i on total PT Na+ reabsorption is small. Na+/H+ exchanger 3 (NHE3) accounts for the bulk of PT Na+ reabsorption. E and F: in cases 3 and 4, when SGLT2 inhibition also triggers NHE3 inhibition, total and fractional PT Na+ reabsorption is reduced, primarily because of reduced reabsorption through NHE3.